Technetium Tc-99M Pyrophosphate Kit Injection shortage
Technetium Tc-99M Pyrophosphate Kit Injection is currently listed in shortage by the FDA. The FDA lists 3 affected products. The reported reason: Other; Shortage of an active ingredient. This page was last refreshed from FDA data on Oct 3, 2026.
Technetium Tc-99m pyrophosphate kit injection is in a severe, ongoing shortage that has lasted over a year, affecting all available strengths. No manufacturer currently has supply, and no other makers of this product have been identified as alternatives.
Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers and your prescriber about a long-term plan.
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Technetium Tc-99M Pyrophosphate Kit Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Oct 1, 2026Currently in shortage3 of 3 products affected.
-
Sep 18, 2026FDA refreshed this shortage record2 products updated.
-
Dec 27, 2023First reported to the FDA3 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Curium US LLC 📞 888-744-1414 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Technescan PYP, Injection, 11.9 mg/10 mL; 3.2 mg/10 mL (NDC 69945-094-20) | — | Limited Availability | On allocation | Shortage of an active ingredient |
Manufacturer: Sun Pharmaceutical Industries, Inc. 📞 800-818-4555 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-1) | — | Unavailable | Estimated Recovery: TBD | Other |
| Current | CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-2) | — | Unavailable | Estimated Recovery: TBD | Other |
These rows are manufacturer reports to the FDA for Technetium Tc-99M Pyrophosphate Kit Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Technetium Tc-99M Pyrophosphate Kit Injection? options further down this page.
Why is Technetium Tc-99M Pyrophosphate Kit Injection in shortage?
Right now, there are two manufacturers affected by this shortage, and each has a slightly different reason. For Sun Pharmaceutical Industries, both of their CIS-PYRO 12 mg/10 mL vials are currently unavailable, and unfortunately they haven't given a specific public reason or an estimated return date — just "to be determined." For Curium US LLC, their Technescan PYP (11.9 mg/10 mL and 3.2 mg/10 mL) is also unavailable, but they have been more specific: the problem is a shortage of the active ingredient needed to make the product, and they estimate they won't have it back in supply until late September 2026.
It's worth knowing that this report only covers these two manufacturers and their specific products. Other companies that make this type of medication may have filed separate reports, so the full picture of availability across all makers may look different than what's shown here.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Technetium Tc-99M Pyrophosphate Kit Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Technetium Tc-99M Pyrophosphate Kit Injection?
Technetium Tc-99M Pyrophosphate Kit Injection is currently on the FDA drug-shortage list. This is a specialized product used in certain imaging scans, so your care is usually coordinated through the facility that performs the test.
At this time, every listed strength is reported as unavailable: 12 mg/10 mL, 11.9 mg/10 mL, and 3.2 mg/10 mL. No strength currently has an available source in this data.
The reasons given are a shortage of an active ingredient and "other" supply issues. Two manufacturers are on this record, and both report their products as unavailable. Recovery timing varies: for the 11.9 mg/10 mL and 3.2 mg/10 mL kit, recovery is estimated for late September 2026, while the 12 mg/10 mL kit is listed as "to be determined." This shortage has lasted over a year, so plans may need to be flexible.
Here is what you can do:
- Do not skip or change anything on your own — talk with the team managing your scan first.
- Ask your imaging facility or pharmacy to check wholesalers and both manufacturers, since local supply may differ from national data.
- If your kit cannot be found, ask your prescriber about timing your scan or a clinician-chosen alternative approach.
Manufacturer contact numbers are listed on this page for reference; facilities usually handle these calls.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Therapeutic equivalents & pricing 3 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Technescan PYP 11.9 mg/10mL; 3.2 mg/10mL | Curium | 5 vials | — | AP | FDA listed |
| Kit for the Preparation of Technetium Tc99m Pyrophosphate 12 mg/10mL | Sun | 5 vials | — | AP | FDA listed |
| Kit for the Preparation of Technetium Tc99m Pyrophosphate 12 mg/10mL | Sun | 30 vials | — | AP | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Technetium Tc-99M Pyrophosphate Kit Injection — that fall in the same broad treatment class (cardiovascular diagnostics - radioactive) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other medical imaging shortages
Technetium Tc-99M Pyrophosphate Kit Injection shortage FAQs
Is Technetium Tc-99M Pyrophosphate Kit Injection in shortage?
Why is Technetium Tc-99M Pyrophosphate Kit Injection in shortage?
Which products are affected?
When will Technetium Tc-99M Pyrophosphate Kit Injection be available again?
What should I do if I take Technetium Tc-99M Pyrophosphate Kit Injection?
Still have a question about the Technetium Tc-99M Pyrophosphate Kit Injection shortage?
Ask a pharmacist about this shortage →View Technetium Tc-99M Pyrophosphate Kit Inje... on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.